Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Magnetic Resonance Assessment of Victoza Efficacy in the Regression of Cardiovascular Dysfunction In Type 2 Diabetes Mellitus and South Asian Descent

NCT02660047 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT02660047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02660047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Magnetic Resonance Assessment of Victoza Efficacy in the Regression of Cardiovascular Dysfunction In Type 2 Diabetes Mellitus and South Asian Descent
Lead sponsor
Leiden University Medical Center
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2015
Completion date
March 9, 2018
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, diabetes mellitus type 2, diastolic dysfunction, fatty liver, metabolic syndrome